T. Yoshida et al., MICROINJECTION OF INTACT MAP-4 AND FRAGMENTS INDUCES CHANGES OF THE CYTOSKELETON IN PTK2 CELLS, Cell motility and the cytoskeleton, 33(4), 1996, pp. 252-262
The molecular cloning and sequencing of microtubule-associated protein
(MAP)-4 identified microtubule-binding repeats near the C-terminus an
d a projection domain near the N-terminus. Although it is well known t
hat MAP-4 stimulates the assembly of and stabilizes microtubules (MT)
in vitro, the function of MAP-4 in vivo is still unclear. In this stud
y, we examined the function of MAP-4 in the cytoskeleton both in vitro
and in vivo. Intact MAP-4 was prepared from bovine adrenal cortex, an
d the truncated fragments of the N- and the C-terminal halves (named N
R and PA(4) fragments, respectively) were expressed in Escherichia col
i and isolated. In vitro studies demonstrated that in a solution conta
ining a physiological concentration of NaCl, intact MAP-4 and the PA(4
) fragment were bound to MT, but not to F-actin. The NR fragment was n
ot bound to MT or to F-actin. We also examined the MT changes in PtK2
cells after they had been microinjected with intact MAP-4 and the trun
cated fragments of PA(4) and NR. The injection of intact MAP-4 or PA(4
) into the cells induced an increase in the number of cytoplasmic MT,
as well as MT bundling. The NR fragment did not affect the MT array. I
njected MAP-4 and PA(4) were associated with the increased MT. In addi
tion, injection with MAP-4 and PA(4) stabilized MT in relation to trea
tment with the MT-disrupting drug, nocodazole. These results indicated
that intact MAP-4 and the PA(4) fragment promoted MT assembly and sta
bilized MT, by binding to MT, in vivo as well as in vitro. Further, th
e injection of the PA4 fragment induced an increase in stress fibers.
However, these proteins did not show any association with the stress f
ibers. Our results suggest that there is an indirect effect of MAP-4 o
n stress fibers rather than a direct interaction between MAP-4 and str
ess fibers. (C) 1996 Wiley-Liss, Inc.